Article 11 Feb 2026 Semaglutide vs. Tirzepatide: A Groundbreaking Real-World Analysis on Cardiovascular Outcomes in Overweight and Obese Patients Manuscript Summaries
Article 5 Feb 2026 Repurposing Anti-diabetic GLP-1 Receptor Agonists: A Promising Frontier in Alzheimer’s Disease Treatment Manuscript Summaries
Article 10 Nov 2025 One-year usage patterns of SGLT-2 inhibitors and GLP-1 receptor agonists in individuals with type 2 diabetes in a real-world population Manuscript Summaries
Article 10 Nov 2025 SGLT2 Inhibitor and GLP-1 Receptor Agonist Prescriptions in Newly Diagnosed Type 2 Diabetes Patients With Cardiorenal Risks: A Cross-Sectional Study Manuscript Summaries
Article 30 Oct 2025 Macrovascular and microvascular outcomes of metabolic surgery versus GLP-1 receptor agonists in patients with diabetes and obesity Manuscript Summaries
Article 30 Oct 2025 Obesity Treatment With Bariatric Surgery vs GLP-1 Receptor Agonists Manuscript Summaries
Article 14 Oct 2025 The Dual Impact of GLP-1 Receptor Agonists on Metabolic and Reproductive Health in Polycystic Ovary Syndrome: A Comprehensive Review for Healthcare Professionals Manuscript Summaries
Article 11 Sep 2025 The role of glucagon-like peptide-1 receptor agonists in weight regain treatment or prevention after bariatric surgery: a systematic review and meta-analysis Manuscript Summaries
Article 7 Sep 2025 Gastrointestinal Adverse Events with GLP-1 Receptor Agonists in Non-Diabetic Weight Management Manuscript Summaries
Article 7 Sep 2025 GLP-1 Receptor Agonists in Type 2 Diabetes After PCI: Impact on Cardiovascular Outcomes and Coronary Lesion Progression Manuscript Summaries
Article 5 Sep 2025 Primary Care Obesity Management in England: A Comprehensive Review for Healthcare Professionals Manuscript Summaries